Assessment 2: Problem Statement (PICOT)
Mabel Grace
Capella University
Instructor’s Name
April, 2024
Problem Statement (PICOT)
In addressing the complex challenge of managing chronic pain in cancer patients, this problem statement assessment aims to offer a thorough examination of the pertinent data, intervention techniques, and underlying need in the context of oncology care settings. Chronic pain poses significant physical, emotional, and psychological burdens on cancer patients, impacting their quality of life, treatment adherence, and overall outcomes (Wilson et al., 2022). By delineating the scope of the problem this assessment seeks to lay the groundwork for developing effective strategies to enhance pain management practices and improve the well-being of cancer patients undergoing treatment or palliative care. The PICOT question for this project is mentioned below:
Does the use of comprehensive pain management strategies, as opposed to standard care alone (P), increase pain relief, functional status, and quality of life (O) in cancer patients receiving treatment or palliative care during a six- to one-year-long period (T)?
Part 1: Problem Statement
Need Statement
Addressing the management of chronic pain in cancer patients encompasses a multifaceted need within oncology care. The assumption underlying this analysis is that chronic pain is a prevalent and significant concern among individuals undergoing cancer treatment or palliative care. Research consistently indicates that a substantial proportion of cancer patients experience chronic pain due to tumor growth, treatment-related side effects, or comorbid conditions (Emery et al., 2022). Moreover, it is assumed that uncontrolled pain not only diminishes the quality of life for these patients but also hampers their ability to adhere to treatment regimens and participate in activities essential for their well-being.
While the complexities of cancer-related pain require a tailored approach, evidence suggests that multimodal interventions incorporating pharmacological and non-pharmacological strategies can effectively alleviate pain and improve overall functioning (Shi & Wu, 2023). This assumption underscores the importance of implementing comprehensive pain management programs within oncology clinics and palliative care settings, where specialized resources and expertise are available to address the unique needs of cancer patients.
Population and Setting
To address the identified need of managing chronic pain in cancer patients, a quality improvement method that will significantly impact patient outcomes is the implementation of a standardized pain management protocol. As part of this protocol, pain will be systematically assessed at regular intervals during cancer treatment or palliative care using validated instruments like the Edmonton Symptom Assessment System or the Brief Pain Inventory (Tan et al., 2023). Based on the assessment findings, a multidisciplinary team consisting of oncologists, nurses, pain specialists, pharmacists, and psychosocial support staff will collaborate to develop individualized pain management plans incorporating pharmacological and non-pharmacological interventions, supportive care services, and patient education.
However, several potential challenges may arise when working on this identified need with the target population of cancer patients undergoing treatment or palliative care. Firstly, there may be variability in pain severity, etiology, and treatment response among cancer patients due to differences in cancer type, stage, and treatment modalities, requiring a flexible and individualized approach to pain management. Additionally, cancer patients often experience comorbidities, such as neuropathy, fatigue, and mood disorders, which can complicate pain assessment and management and necessitate a holistic approach to addressing their complex needs (Mestdagh et al., 2023). Furthermore, healthcare providers may encounter barriers to implementing standardized pain management protocols, including time constraints, resource limitations, and resistance to change, particularly in busy oncology care settings where competing priorities and administrative burdens may impact the delivery of comprehensive pain care.
Intervention overview
One intervention to drive quality improvement in managing chronic pain among cancer patients within oncology care settings involves the implementation of comprehensive pain management clinics. These clinics serve as specialized centers where patients can receive multidisciplinary care tailored to their unique pain profiles and treatment needs. In such clinics, patients have access to a range of services, including pain assessment, medication management, physical therapy, psychological support, and complementary therapies (Buonanno et al., 2022). However, one weakness of this intervention is the potential for resource constraints, including limited staffing, equipment, and funding, which may affect the clinic’s capacity to meet the needs of all patients in a timely manner.
Another intervention is the integration of telemedicine platforms into oncology care to provide remote pain management services for cancer patients. Telemedicine eliminates the need for in-person appointments and lowers barriers to care by enabling patients to interact with medical professionals, including pain experts, via phone calls, secure messaging apps, or virtual visits (Buonanno et al., 2022). However, a weakness of this intervention is the digital divide, which may limit access to telemedicine services for certain patient populations, particularly those with limited internet connectivity or digital literacy skills. Additionally, concerns regarding patient privacy, data security, and the quality of care delivered through telemedicine platforms must be addressed to ensure the effectiveness and safety of this intervention.
Comparison of Approaches
One possible interprofessional substitute for the first comprehensive intervention, pain management clinics is the establishment of pain management consultation teams within oncology care settings. These teams will consist of healthcare professionals from various disciplines, including oncologists, pain specialists, nurses, pharmacists, physical therapists, and psychologists, who collaborate to assess and address the pain needs of cancer patients. This approach allows for a flexible and responsive model of care delivery, where patients can receive timely consultations and interventions from a diverse team of experts (Shrestha et al., 2023). However, a weakness of this alternative is the potential for coordination challenges and communication barriers among team members, which may impact the continuity and effectiveness of care delivery.
Another interprofessional alternative is the implementation of collaborative care pathways for pain management in cancer patients. These pathways involve the development of standardized protocols and guidelines, treating, and monitoring pain in cancer patients (Tam et al., 2023). By establishing clear pathways for care delivery, this approach will promote consistency and continuity in pain management practices across the oncology care continuum. However, a weakness of this alternative is the potential for resistance to change among healthcare providers who may be accustomed to traditional care models. Overcoming inertia and fostering buy-in from stakeholders may require ongoing education, training, and support.
Initial Outcome Draft
An outcome related to health policy could be the establishment of reimbursement policies that ensure equitable access to comprehensive pain management services for all patients undergoing oncology care. The purpose of this outcome within this project is to address disparities in access to pain management interventions by implementing policies that incentivize healthcare providers to deliver evidence-based pain management interventions and support services tailored to the unique needs of cancer patients. The intended accomplishments of this intervention include improving patient outcomes, enhancing the quality of care delivered in oncology settings, and reducing the burden on patients and caregivers associated with uncontrolled pain (Calton et al., 2023).
To evaluate the achievement of this outcome, several criteria can be considered. Firstly, I will assess the access and equity aspect by examining the extent to which reimbursement policies have increased access to pain management services for underserved populations of cancer patients, including those in rural areas, minority groups, and individuals facing financial constraints. Secondly, I will analyze utilization and adherence patterns among healthcare providers to ensure that evidence-based pain management practices and guidelines are being followed consistently.
Furthermore, I will assess healthcare utilization trends before and after the implementation of reimbursement policies, including emergency department visits, hospital admissions, and healthcare costs related to pain management, to gauge the effectiveness of the policies in reducing the burden on the healthcare system. Provider engagement and satisfaction with reimbursement policies will also be evaluated to understand their perceived impact on practice workflows, financial sustainability, and ability to deliver high-quality care. Finally, I will assess the broader impact of reimbursement policies on health system outcomes, including their alignment with national quality improvement initiatives, adherence to regulatory standards, and contribution to population health goals.
Time Estimate
A suggested timeline for both the development and implementation of an intervention could be delineated in the following manner:
During the development phase, which spans approximately 6 to 9 months, the focus will be on conducting a thorough needs assessment specific to our target population of cancer patients undergoing treatment or palliative care. This assessment will involve gathering data on pain prevalence, severity, and associated factors, as well as understanding the existing pain management practices and challenges within the oncology care settings. Drawing upon existing evidence-based guidelines and best practices, the intervention components will be meticulously designed to address the identified pain management needs. This includes the development of comprehensive protocols for pain assessment, treatment algorithms tailored to different cancer types and treatment modalities, educational materials for both patients and healthcare providers, and training modules to enhance staff competencies in pain management practices. Additionally, a pilot test of the intervention will be conducted in a select oncology clinic to assess its feasibility, acceptability, and initial effectiveness, allowing for iterative refinement before full-scale implementation.
The implementation phase, spanning approximately 12 to 18 months, will involve the systematic rollout of the intervention across the targeted oncology care settings. This phase will necessitate extensive coordination and collaboration among multidisciplinary teams of healthcare providers, including oncologists, nurses, pain specialists, psychologists, and support staff. Adequate training and support will be provided to ensure the successful integration of the intervention into routine clinical workflows. Continuous monitoring of implementation fidelity and adherence to intervention protocols will be conducted, alongside ongoing data collection on process measures such as patient screenings, treatment adherence, and patient satisfaction. Short-term outcomes, including changes in pain severity, functional status, and healthcare utilization, will be evaluated to assess the effectiveness of the intervention in achieving its objectives. Throughout the implementation phase, adjustments and refinements to the intervention will be made based on real-time feedback from stakeholders and emerging evaluation findings to optimize its impact and sustainability.
Despite the proposed time frame, several areas of uncertainty and knowledge gaps may impact the project’s progress. These include potential challenges related to stakeholder engagement and organizational readiness for change, as well as external factors such as policy changes and resource constraints. Mitigating these uncertainties will require ongoing monitoring, flexibility, and adaptability in project planning and implementation strategies.
Part 2: Literature Review
In validating the identified need of managing chronic pain in cancer patients within our target population of oncology patients undergoing treatment or palliative care, it is crucial to analyze current evidence from a variety of reputable sources. Research published in peer-reviewed journals underscores the significant prevalence of chronic pain within the cancer patient population, with estimations ranging around 47% (Haenen et al., 2022). Furthermore, clinical practice emphasizes the importance of comprehensive pain assessment and multimodal pain management approaches tailored to the individual needs of cancer patients (Mestdagh et al., 2023). Likewise, systematic reviews and meta-analyses offer substantial evidence advocating for the efficacy of interventions like opioid analgesics, adjuvant medications, and non-pharmacological therapies in alleviating pain associated with cancer (Kettyle, 2023).
The relevance, sufficiency, and trustworthiness of the evidence must be critically evaluated to ensure its applicability to our project. Relevance entails assessing the extent to which the evidence aligns with the specific needs and characteristics of our target population of cancer patients receiving treatment or palliative care. Sufficiency involves determining the breadth and depth of the evidence base, including the quantity and diversity of studies available to support our understanding of the identified need and its implications for practice. The credibility of research is assessed through the thoroughness and reliability of the methodology employed, encompassing elements such as study design, sample size, data collection techniques, analysis methods, and transparency in presenting results.
Healthcare Policy that Impacts the Approach to Address an Identified Need
In evaluating and synthesizing resources relevant to our project of managing chronic pain in cancer patients, it is crucial to examine existing health policies. Specifically, health policies such as the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Adult Cancer Pain provide essential frameworks and recommendations for pain assessment, treatment, and supportive care services in oncology settings (Scheffer et al., 2023). Additionally, health policy initiatives aimed at improving access to palliative care services, enhancing reimbursement for pain management interventions, and promoting patient-centered care models may impact the implementation of comprehensive pain management strategies for cancer patients. Furthermore, analyzing the role of healthcare technologies in facilitating pain assessment, monitoring, and communication between patients and providers can offer insights into innovative approaches to enhancing pain management outcomes in oncology care (Shaverdian et al., 2021).
Despite the wealth of information available on health policy and healthcare technologies relevant to pain management in cancer care, there may be missing information related to specific health policies that directly impact our project. For instance, gaps in health policy related to reimbursement for integrative pain management modalities, such as acupuncture, massage therapy, and mind-body interventions, hinder the delivery of comprehensive pain care for cancer patients (Manchikanti et al., 2020). Similarly, disparities in access to palliative care services based on geographic location, socioeconomic status, or insurance coverage limit the availability of multidisciplinary pain management interventions for underserved populations. Additionally, variations in state-level opioid prescribing regulations and formulary restrictions pose challenges to implementing standardized pain management protocols across diverse healthcare settings. Addressing these missing pieces of information through policy analysis, stakeholder engagement, and advocacy efforts is essential to informing strategies for improving pain management outcomes and promoting health equity in oncology care.
NURS FPX 6030 Assessment 2 Problem Statement (PICOT) Conclusion
Addressing the challenge of managing chronic pain in cancer patients through comprehensive pain management interventions holds significant promise for improving patient outcomes and enhancing the quality of care in oncology settings. By implementing evidence-based approaches tailored to the individual needs of cancer patients, including multimodal analgesia, interdisciplinary care, and supportive services, healthcare providers can strive to alleviate pain, enhance functional status, and promote overall well-being among this vulnerable population. However, further research and evaluation are warranted to address existing gaps in health policy and healthcare delivery that hinder optimal pain management practices in oncology care.
NURS FPX 6030 Assessment 2 Problem Statement (PICOT) References
Buonanno, P., Marra, A., Iacovazzo, C., & Franco, M. (2022). Telemedicine in cancer pain management: A systematic review and meta-analysis of randomized controlled trials. Pain Medicine, 24(3), 226–233. https://doi.org/10.1093/pm/pnac128
Calton, B. A., Nouri, S., Davila, C., Kotwal, A., Zapata, C., & Bischoff, K. E. (2023). Strategies to make telemedicine a friend, not a foe, in the provision of accessible and equitable cancer care. Cancers, 15(21), 5121–5121. https://doi.org/10.3390/cancers15215121
Emery, J., Butow, P., Lai-Kwon, J., Nekhlyudov, L., Rynderman, M., & Jefford, M. (2022). Management of common clinical problems experienced by survivors of cancer. The Lancet, 399(10334), 1537–1550. https://doi.org/10.1016/s0140-6736(22)00242-2
Haenen, V., Evenepoel, M., Baerdemaecker, T., Meeus, M., Devoogdt, N., Morlion, B., Dams, L., Van Dijck, S., Van der Gucht, E., De Vrieze, T., Vyvere, T. V., & De Groef, A. (2022). Pain prevalence and characteristics in survivors of solid cancers: A systematic review and meta-analysis. Supportive Care in Cancer, 31(1). https://doi.org/10.1007/s00520-022-07491-8
Kettyle, G. (2023). Multidisciplinary approach to cancer pain management. The Ulster Medical Journal, 92(1), 55–58. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899029/
Manchikanti, L., Singh, V., Kaye, A. D., & Hirsch, J. A. (2020). Lessons for better pain management in the future: Learning from the past. Pain and Therapy, 9. https://doi.org/10.1007/s40122-020-00170-8
Mestdagh, F., Steyaert, A., & Lavand, P. (2023). Cancer pain management: A narrative review of current concepts, strategies, and techniques. Current Oncology, 30(7), 6838–6858. https://doi.org/10.3390/curroncol30070500
Scheffer, E. R., Rome, R. S., Kesselheim, A. S., & Rome, B. N. (2023). National comprehensive cancer network guideline recommendations of cancer drugs with accelerated approval. JAMA Network Open, 6(11), e2343285–e2343285. https://doi.org/10.1001/jamanetworkopen.2023.43285
Shaverdian, N., Gillespie, E. F., Cha, E., Kim, S. Y., Benvengo, S., Chino, F., Kang, J. J., Li, Y., Atkinson, T. M., Lee, N., Washington, C. M., Cahlon, O., & Gomez, D. R. (2021). Impact of telemedicine on patient satisfaction and perceptions of care quality in radiation oncology. Journal of the National Comprehensive Cancer Network, 19(10), 1174–1180. https://doi.org/10.6004/jnccn.2020.7687
Shi, Y., & Wu, W. (2023). Multimodal non-invasive non-pharmacological therapies for chronic pain: Mechanisms and progress. BMC Medicine, 21(1). https://doi.org/10.1186/s12916-023-03076-2
Shrestha, S., Blebil, A. Q., Teoh, S. L., Sapkota, S., KC, B., Paudyal, V., & Gan, S. H. (2023). Clinical pharmacists’ intervention on pain management in cancer patients (Pharma CAP trial): Study protocol for a randomized controlled trial. Journal of Pharmaceutical Policy and Practice, 16(1). https://doi.org/10.1186/s40545-022-00505-0
Tam, S., Zatirka, T., Neslund, C., Su, W.-T., Cannella, C. E., Grewal, J. S., Mattour, A. H., Tang, A., Movsas, B., & Chang, S. S. (2023). Real time patient‐reported outcome measures in patients with cancer: Early experience within an integrated health system. Cancer Medicine, 12(7), 8860–8870. https://doi.org/10.1002/cam4.5635
Tan, V., Tjong, M. C., Yan, M., Delibasic, V., Darling, G., Davis, L., Doherty, M., Hallet, J., Kidane, B., Mahar, A., Mittmann, N., Parmar, A., Tan, H., Wright, F. C., Coburn, N., & Louie, A. V. (2023). Pain and interventions in stage IV non-small cell lung cancer: A province-wide analysis. Current Oncology, 30(3), 3461–3472. https://doi.org/10.3390/curroncol30030262
Wilson, J. M., Schreiber, K. L., Mackey, S., Flowers, K. M., Darnall, B. D., Edwards, R. R., & Azizoddin, D. R. (2022). Increased pain catastrophizing longitudinally predicts worsened pain severity and interference in patients with chronic pain and cancer: A collaborative health outcomes information registry study (CHOIR). Psycho-Oncology. https://doi.org/10.1002/pon.6020
